Table 1 Groups of Xenograft model of ovarian cancerand treatment
Groups | Mice number | Drug treatment | Concentration and dosage | frequency | weeks |
|---|---|---|---|---|---|
Group A | 5 | NS + DMSO | control 0.1 ml | Treatment 5 days and rest 2 days | 2 weeks |
Group B | 5 | mPEG-PCL+ DMSO | control 0.1Â ml | Treatment 5Â days and rest 2Â days | 2Â weeks |
Group C | 5 | fisetin + mPEG-PCL + DMSO | 50 mg/kg,0.1 ml | Treatment 5 days and rest 2 days | 2 weeks |
Group D | 5 | Fisetin micelles + mPEG-PCL + DMSO | 100 mg/kg,0.1 ml | Treatment 5 days and rest 2 days | 2 weeks |
Group E | 5 | NS + DMSO | control 0.1 ml | Treatment 5 days and rest 2 days | 2 weeks |
Group F | 5 | mPEG-PCL+ DMSO | control 0.1Â ml | Treatment 5Â days and rest 2Â days | 2Â weeks |
Group G | 5 | fisetin + mPEG-PCL + DMSO | 50 mg/kg,0.1 ml | Treatment 5 days and rest 2 days | 2 weeks |
Group H | 5 | Fisetin micelles + mPEG-PCL + DMSO | 100 mg/kg,0.1 ml | Treatment 5 days and rest 2 days | 2 weeks |